13F

Stock

Sinovac Biotech Ltd

SVA · held by 28 managers

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025

Reported value

$223.3M

Holders

28

+0 new · −0 exited

Holders’ est. mark

$0

Price effect on 3 books still in the name

Largest holder

$184.5M

ORBIMED ADVISORS LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Q3 2025Q4 2025Q1 2026

Who holds it

Notable only
InvestorSharesValueEst. markChange
ORBIMED ADVISORS LLC2.72M$184.5M—Held
Vivo Capital, LLC5.9M$38.2M—Held
Aprio Wealth Management, LLC439$284K—Held
WELLS FARGO & COMPANY/MN16.9K$109.2K—Held
SUSQUEHANNA INTERNATIONAL GROUP, LLP16.4K$106.3K—Held
UBS Group AG9.22K$59.7K—Held
MORGAN STANLEY9.14K$59.2K$0Held
Neumann Advisory Hong Kong Ltd315.6K$2.04K—Held
Horizon Investments, LLC52$336—Held
ASSETMARK, INC26$0—Held
Transamerica Financial Advisors, LLC1$0—Held
Tower Research Capital LLC (TRC)424$0—Held
Skandinaviska Enskilda Banken AB (publ)40K$0—Held
Spark Investment Management LLC29.1K$0—Held
FINANCIAL CONSULATE, INC23$0—Held
IFP Advisors, Inc200$0$0Held
OSAIC HOLDINGS, INC.1.99K$0—Held
Financial Gravity Asset Management, Inc.23$0—Held
BANK OF AMERICA CORP /DE/5.89K$0$0Held
Atlantic Edge Private Wealth Management, LLC1K$0—Held
JONES FINANCIAL COMPANIES LLLP338$0—Held
Clearstead Advisors, LLC500$0—Held
NAVELLIER & ASSOCIATES INC13K$0—Held
California Public Employees Retirement System68.7K$0—Held
ROYAL BANK OF CANADA425$0—Held
Renaissance Technologies1.31M$0—Held
MAI Capital Management3$0—Held
GEODE CAPITAL MANAGEMENT, LLC27.7K$0—Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.